HOME >> MEDICINE >> NEWS
NIH launches National Commission on Digestive Diseases

Bethesda, Maryland (Sept. 14, 2005) This week, Director of the National Institutes of Health (NIH) Elias A. Zerhouni, MD, announced the establishment of the National Commission on Digestive Diseases. This is a major victory for patients with digestive diseases and for the AGA, which has worked tirelessly for the creation of the Commission.

Consistent with AGA legislative language included in an appropriations bill signed into law by President Bush last year, NIH and the Department of Health and Human Services (HHS) will develop a Long-Range Plan for Digestive Diseases to focus on the needs of gastroenterologists and their patients.

"The creation of the National Commission on Digestive Diseases is a landmark event in the advancement of the science and practice of gastroenterology," said David A. Peura, MD, AGA president. "Our goal in proposing the Commission was to obtain the funds and focus needed to increase the rate of discovery and to translate advances into clinical practice."

The Commission will assess the state-of-the-science in digestive diseases and the related NIH research portfolio, with a view toward identifying areas of research challenge and opportunity. The Commission's Research Plan will then guide the NIHalong with the investigative and lay communitiesin pursuing important research avenues to combating digestive diseases.

In 1976, Congress created the Commission on Digestive Diseases Research, which proposed a long-term plan and made recommendations that laid the groundwork for significant progress in the area of digestive health. The newly mandated National Commission on Digestive Diseases will update the findings of the original Commission and will be composed of scientists, physicians, patient advocates and representatives of federal agencies.

According to "The Burden of Gastrointestinal Diseases," a study conducted by the AGA in 2001, disorders of the digestive tract comprise a spectrum of gastroin
'"/>

Contact: Kimberly Wise
media@gastro.org
301-941-2620
American Gastroenterological Association
16-Sep-2005


Page: 1 2

Related medicine news :

1. Worlds largest respiratory health study launches next phase
2. Elsevier launches the Clinics on ScienceDirect
3. Elsevier launches Molecular Oncology
4. Kennedy Krieger Institute launches first national online autism registry
5. UW launches study testing adult stem cells for heart damage repair
6. IEEE-USA launches critical infrastructure protection committee
7. Liverpool launches 20 million project to develop medicines for children
8. ESSP launches project on the effects of global environmental change on human health
9. ACP re-launches magazine for hospitalists
10. The Starr Foundation launches multi-institutional cancer consortium
11. Rochester launches Cancer Stem Cell Research Program

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH launches National Commission Digestive Diseases

(Date:5/22/2013)... and Los Angeles, CA (PRWEB) May 22, 2013 ... the board, The J. M. Smucker Company, and ... Achievement Awards yesterday at the GS1 General Assembly and ... California. Mr. Smucker and Mr. Wegman were recognized for ... GS1 Standards - the most broadly used supply chain ...
(Date:5/22/2013)... May 22 (HealthDay News) -- Children and teens exposed ... likely to develop cancer, according to a large, long-term ... a group of 10,000 young people who each had ... be expected to occur within 10 years, according to ... doctors should carefully weight the risks to patients when ...
(Date:5/22/2013)... available in German . ... Foundation) is establishing 11 new Research Training Groups to ... was made by the relevant Grants Committee in Bonn. ... to the new programmes for an initial period of ... 11 new Research Training Groups, the Grants Committee approved ...
(Date:5/22/2013)... run, encouraging a baby to finish the last ounce in ... Though the calories soon burn off, a bad habit remains. ... Forste found that clinical obesity at 24 months of age ... overweight at age two, it puts you on a trajectory ... and adolescence and as an adult," said Forste. "That,s a ...
(Date:5/22/2013)... May 22, 2013 The new 13-valent pneumococcal ... the previous version used prior to 2010, the 7-valent ... study published today in Vaccine . , The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...
Breaking Medicine News(10 mins):Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Overeating learned in infancy, study suggests 2Health News:Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine 2
(Date:5/22/2013)... -- Cellular Biomedicine Group (OTCQB: CBMG) today announced that it ... enrollment required for its Phase I trial to evaluate the ... Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most common ... no Severe Adverse Effect (SAE) reported. The Phase ... NIH under number NCT01828762 (click here to view) ...
(Date:5/22/2013)... May 22, 2013 PRNewswire – iBio, ... of a vaccine candidate for the newly emerged ... laboratory using the iBioLaunch™ platform. This validation milestone ... initial antigen sequence information to purification of recombinant ... ) The iBioLaunch platform eliminates the ...
(Date:5/22/2013)... TEL AVIV, Israel , May 22, 2013 /PRNewswire/ ... "Company") (TASE, NASDAQ: EMITF) announced today, further to the ... filed a motion with the Tel Aviv ... of its unsecured creditors and shareholders for the approval ... debt pursuant to a plan of arrangement (the "Arrangement") ...
Breaking Medicine Technology:Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 2Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 3iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 3
Cached News: